Cancer vaccine breakthrough extends disease-free period in trial

A new cancer vaccine extended the length of time patients remained disease-free in a clinical trial, according to new research. It remains unclear how long the protective effect lasts. Scientists describe the results as promising but say further research is needed before broader conclusions can be drawn.